A detailed history of Fortis Group Advisors, LLC transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Fortis Group Advisors, LLC holds 50 shares of ZBH stock, worth $5,362. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Previous 50 -0.0%
Holding current value
$5,362
Previous $5.43 Million 0.52%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$119.98 - $132.61 $5,999 - $6,630
-50 Reduced 50.0%
50 $6.6 Million
Q4 2023

Mar 04, 2024

BUY
$102.72 - $121.7 $5,136 - $6,085
50 Added 100.0%
100 $12.2 Million
Q3 2023

Dec 01, 2023

BUY
$110.76 - $143.18 $5,538 - $7,159
50 New
50 $5.61 Million
Q1 2023

May 26, 2023

SELL
$121.91 - $130.94 $6,095 - $6,547
-50 Closed
0 $0
Q3 2020

Nov 17, 2020

BUY
$113.59 - $141.68 $5,679 - $7,084
50 New
50 $6,000

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $22.5B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Fortis Group Advisors, LLC Portfolio

Follow Fortis Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortis Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortis Group Advisors, LLC with notifications on news.